Overview

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

Status:
Recruiting
Trial end date:
2028-10-30
Target enrollment:
Participant gender:
Summary
The aim of the ShorTrip trail is to evaluate the activity and the safety of total neoadjuvant strategy with FOLFOXIRI as consolidation therapy preceded by short-course radiotherapy and followed by surgery in LARC patients.
Phase:
Phase 2
Details
Lead Sponsor:
Gruppo Oncologico del Nord-Ovest
Treatments:
Fluorouracil
Irinotecan
Oxaliplatin